Yann Cheli
4PUBLICATIONS
13CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Oct 24, 2025
SETDB1 is critically required for uveal melanoma growth and represents a promising therapeutic target.Imène Krossa, Céline Pisibon, Yann Cheli
|Sep 28, 2021
Immune Checkpoints in Cancers: From Signaling to the Clinic.Céline Pisibon, Amira Ouertani, Corine Bertolotto
|Jan 08, 2021
ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity.Yann Cheli, Meri K Tulic, Najla El Hachem
|May 18, 2019
Innate lymphocyte-induced CXCR3B-mediated melanocyte apoptosis is a potential initiator of T-cell autoreactivity in vitiligo.Meri K Tulic, Elisa Cavazza, Yann Cheli
Pageof 1
Frequent Collaborators
1 joint publications
Meri K Tulic
1 joint publications
Arnaud Jacquel
1 joint publications
Carmelo Luci
1 joint publications
Maéva Gesson
1 joint publications
Guillaume E Beranger
1 joint publications
Cedric Lereverend
1 joint publications
Thierry Passeron
1 joint publications
Céline Pisibon
1 joint publications
Julien Cherfils-Vicini
1 joint publications
Andrew E Aplin
